
201 - 500 employees
Founded 1992
🧬 Biotechnology
💊 Pharmaceuticals
💰 $250M Post-IPO Debt - Geron on 2024-11
Biotechnology • Pharmaceuticals
Geron is a biotechnology company focused on developing medicines that inhibit telomerase to treat myeloid hematologic malignancies and other blood cancers. The company conducts research and development and clinical trials, reports an R&D pipeline and patient-focused programs, and notes that it has a medicine approved for use in the United States. Geron emphasizes a mission to extend and enhance patients' lives, corporate governance, and equal employment practices.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 1 hour ago
Remote Oncology Key Account Manager expanding pharmaceutical market share across Louisiana and Mississippi. Managing prescriber relationships, clinical presentations, account plans, and oncology product adoption.
⚜️ Louisiana, Mississippi – Remote
💵 $195k - $205k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager
👻 Ghost score 0%
🕒 June 18
Regional Medical Scientific Director serving as a trusted partner for scientific exchange and medical education. Covers California, Nevada, Hawaii, and Arizona with remote work options.
🌵 Arizona, California, +2 more states – Remote
💵 $230k - $245k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 12%